The practical protocol: supplement sodium (2,000 to 3,000mg above dietary intake), potassium (1,000 to 2,000mg), and magnesium (300 to 400mg, preferably glycinate or malate form)
The Medicare GLP-1 Bridge is a short-term CMS demonstration providing eligible Part D beneficiaries with access to certain GLP-1 drugs for obesity at a flat $50 monthly copay, running July 1, 2026 through December 31, 2027
Weight loss results with Tirzepatide vary from person to person, as factors like dosage, individual metabolism, diet, and physical activity play an important role
There is no official guideline on how soon you can start a GLP-1 after giving birth